Published in Curr Genomics on August 01, 2009
Lung development: orchestrating the generation and regeneration of a complex organ. Development (2014) 1.66
Cigarette smoking and DNA methylation. Front Genet (2013) 1.48
Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation. Epigenetics (2014) 1.47
The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget (2015) 1.27
Prenatal exposure to maternal cigarette smoking and DNA methylation: epigenome-wide association in a discovery sample of adolescents and replication in an independent cohort at birth through 17 years of age. Environ Health Perspect (2014) 1.17
Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer. PLoS One (2012) 1.03
The epigenetic control of E-box and Myc-dependent chromatin modifications regulate the licensing of lamin B2 origin during cell cycle. Nucleic Acids Res (2012) 0.88
miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. J Transl Med (2015) 0.87
Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. J Pharmacol Exp Ther (2013) 0.85
Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells. J Exp Clin Cancer Res (2015) 0.82
Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Transl Oncol (2012) 0.81
Ectopic ERK expression induces phenotypic conversion of C10 cells and alters DNA methyltransferase expression. BMC Res Notes (2012) 0.81
DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia. Cancer Cell Int (2013) 0.79
CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer. Cancer Gene Ther (2015) 0.79
Lung Endoderm Morphogenesis: Gasping for Form and Function. Annu Rev Cell Dev Biol (2015) 0.78
Quantitative evaluation of DNMT3B promoter methylation in breast cancer patients using differential high resolution melting analysis. Res Pharm Sci (2013) 0.78
Physiological and pathological implications of 5-hydroxymethylcytosine in diseases. Oncotarget (2016) 0.75
MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner. Med Sci Monit (2016) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
The epigenomics of cancer. Cell (2007) 30.91
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet (2003) 25.57
Stability and flexibility of epigenetic gene regulation in mammalian development. Nature (2007) 14.57
The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature (2007) 11.14
Cellular differentiation, cytidine analogs and DNA methylation. Cell (1980) 10.15
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A (2007) 9.82
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature (2002) 9.51
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet (1998) 7.52
Dnmt3L and the establishment of maternal genomic imprints. Science (2001) 7.42
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 7.09
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov (2002) 6.97
DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet (2000) 6.57
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38
Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02
DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med (2008) 5.87
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet (2000) 5.72
Many paths to methyltransfer: a chronicle of convergence. Trends Biochem Sci (2003) 5.65
Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol (1988) 5.24
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol (2001) 5.03
DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol (2005) 5.02
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet (2006) 4.86
Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development (2002) 4.72
DNA methylation and cancer. J Clin Oncol (2004) 4.58
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies. Blood (2003) 4.07
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res (2003) 3.72
Transgenerational stability of the Arabidopsis epigenome is coordinated by CG methylation. Cell (2007) 3.70
Cancer epigenetics. Hum Mol Genet (2005) 3.63
Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell (2004) 3.60
A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J Biol Chem (2002) 3.50
The cancer epigenome--components and functional correlates. Genes Dev (2006) 3.40
Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer (2005) 3.27
Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer (2004) 3.10
5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol (2005) 3.05
DNA methylation: the nuts and bolts of repression. J Cell Physiol (2007) 3.00
Mammalian DNA methyltransferases: a structural perspective. Structure (2008) 2.72
Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat Genet (2007) 2.62
Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res (2008) 2.61
Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell (2007) 2.61
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res (2005) 2.57
Epigenetics and microRNAs. Pediatr Res (2007) 2.52
Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci (2004) 2.49
Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J (2003) 2.43
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst (2005) 2.43
Preferential response of cancer cells to zebularine. Cancer Cell (2004) 2.39
Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell (2007) 2.36
Post-transcriptional nucleotide modification and alternative folding of RNA. Nucleic Acids Res (2006) 2.34
Regional copy number-independent deregulation of transcription in cancer. Nat Genet (2006) 2.33
Molecular genetics of lung cancer. Annu Rev Med (2001) 2.25
Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem (2001) 2.25
DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene (2002) 2.23
Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst (2003) 2.22
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol (2000) 2.21
Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res (2005) 2.19
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A (2003) 2.12
Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res (2003) 2.04
Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis (2005) 2.02
Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer (2006) 2.00
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Ann Oncol (2007) 1.98
TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol Cell (2009) 1.97
Epigenetic changes in cancer. APMIS (2007) 1.96
Dietary polyphenols may affect DNA methylation. J Nutr (2007) 1.96
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst (2000) 1.94
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene (2001) 1.94
A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet (1998) 1.91
Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene (2005) 1.90
The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation. Genes Dev (2002) 1.89
p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res (2001) 1.88
Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 1.86
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res (2004) 1.84
Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer (2006) 1.82
Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res (2001) 1.81
Cancer epigenetics. Oncogene (2003) 1.80
Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol (2005) 1.78
Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism. RNA (2008) 1.76
De novo CpG island methylation in human cancer cells. Cancer Res (2006) 1.73
Reactivating the expression of methylation silenced genes in human cancer. Oncogene (2002) 1.73
Cancer genetics of epigenetic genes. Hum Mol Genet (2007) 1.72
Dnmt2 functions in the cytoplasm to promote liver, brain, and retina development in zebrafish. Genes Dev (2007) 1.69
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev (2008) 1.68
Epigenetic mechanism of rRNA gene silencing: temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation. Mol Cell Biol (2005) 1.66
FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension. Oncologist (2005) 1.66
Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol (2005) 1.65
Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res (2003) 1.65
Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis (2005) 1.60
DNA methylation and breast cancer. Biochem Pharmacol (2004) 1.57
Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis (2007) 1.53
Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res (2005) 1.53
Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol (2006) 1.46
The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity. J Biol Chem (2003) 1.46
Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol (2006) 1.46
Role of DNA methylation in stable gene repression. J Biol Chem (2007) 1.45
Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res (2004) 1.44
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol (2002) 5.82
The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem (2009) 1.74
Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther (2009) 1.71
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood (2003) 1.62
Aldosterone-sensitive repression of ENaCalpha transcription by a histone H3 lysine-79 methyltransferase. Am J Physiol Cell Physiol (2005) 1.56
Generation and characterization of chimeric recombinant AAV vectors. Mol Ther (2003) 1.54
Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis. Dig Dis Sci (2015) 1.50
Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets (2009) 1.46
Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol (2003) 1.29
Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector. J Virol (2002) 1.19
Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J Virol (2004) 1.17
Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res (2005) 1.15
The mitochondrial inner membrane GTPase, optic atrophy 1 (Opa1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. J Biol Chem (2010) 1.14
Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette. Hum Gene Ther (2008) 1.13
Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci (2012) 1.13
Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction. Proc Natl Acad Sci U S A (2007) 1.12
Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas. Int J Cancer (2007) 1.12
Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther (2011) 1.05
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology (2005) 1.05
rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. Hepatology (2005) 1.04
Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin. Clin Cancer Res (2008) 1.04
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther (2007) 1.03
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice. Mol Ther (2010) 1.02
VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer. Genome Biol (2013) 1.00
Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int J Mol Sci (2013) 0.99
Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol Ther (2009) 0.99
Insights on biology and pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-catenin, and NF-κB pathways in osteoarthritis. Curr Pharm Des (2012) 0.96
Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology (2003) 0.93
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Nucleic Acids Res (2013) 0.92
Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors. Int J Cancer (2005) 0.92
Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Hum Gene Ther Methods (2014) 0.91
Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas. J Gene Med (2008) 0.91
Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice. Hepatology (2005) 0.88
Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia. Hum Gene Ther (2006) 0.88
Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interferon Cytokine Res (2013) 0.87
Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice. Cancer Res (2006) 0.87
Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway. Biochem Biophys Res Commun (2012) 0.87
Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Sci (2009) 0.85
Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats. Hum Gene Ther (2009) 0.84
Neuroprotection by saponins. Phytother Res (2014) 0.83
Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion. J Mol Histol (2013) 0.83
Evaluation of anti-inflammatory and antinociceptive activities of Murraya exotica. Pharm Biol (2010) 0.82
Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver. Int J Cancer (2005) 0.82
Systemic elimination of de novo capsid protein synthesis from replication-competent AAV contamination in the liver. Hum Gene Ther (2011) 0.82
Cytoglobin: a novel potential gene medicine for fibrosis and cancer therapy. Curr Gene Ther (2008) 0.82
The jagged-2/notch-1/hes-1 pathway is involved in intestinal epithelium regeneration after intestinal ischemia-reperfusion injury. PLoS One (2013) 0.81
Sequence-based identification of recombination spots using pseudo nucleic acid representation and recursive feature extraction by linear kernel SVM. BMC Bioinformatics (2014) 0.80
[High level expression of recombinant human kallistatin in Pichia pastoris and its bioactivity]. Sheng Wu Gong Cheng Xue Bao (2010) 0.80
The bioreactor: a powerful tool for large-scale culture of animal cells. Curr Pharm Biotechnol (2005) 0.80
A new intracorporeal Billroth II stapled anastomosis technique in totally laparoscopic distal gastrectomy. Surg Endosc (2014) 0.80
Sp1 trans-activates the murine H(+)-K(+)-ATPase alpha(2)-subunit gene. Am J Physiol Renal Physiol (2009) 0.79
Double-stranded Let-7 mimics, potential candidates for cancer gene therapy. J Physiol Biochem (2011) 0.79
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors. Mol Ther (2005) 0.79
Essential role of angiotensin receptors in the modulation of intestinal epithelial cell apoptosis. J Pediatr Gastroenterol Nutr (2013) 0.78
Alternative gene therapy strategies for the repair of craniofacial bone defects. Curr Gene Ther (2004) 0.78
The design of vectors for RNAi delivery system. Curr Pharm Des (2008) 0.78
Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats. J Biomed Sci (2008) 0.78
Engineering Factor Viii for Hemophilia Gene Therapy. J Genet Syndr Gene Ther (2011) 0.78
Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors. Cancer Gene Ther (2005) 0.77
Inhibition of ACE activity contributes to the intestinal structural compensation in a massive intestinal resection rat model. Pediatr Surg Int (2012) 0.77
Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes. Spine (Phila Pa 1976) (2004) 0.77
Gene transfer into human keloid tissue with adeno-associated virus vector. J Trauma (2003) 0.77
Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway. Shock (2016) 0.77
A reliable and feasible qPCR strategy for titrating AAV vectors. Med Sci Monit Basic Res (2013) 0.77
TRAIL: a potential agent for cancer therapy. Curr Mol Med (2003) 0.77
Prediction the Substrate Specificities of Membrane Transport Proteins Based on Support Vector Machine and Hybrid Features. IEEE/ACM Trans Comput Biol Bioinform (2015) 0.76
[Role of cytoglobin in protecting hepatic stellate cells against oxidation induced damage]. Sheng Wu Gong Cheng Xue Bao (2011) 0.76
Scales for evaluating depressive symptoms in Chinese patients with schizophrenia. J Nerv Ment Dis (2009) 0.76
Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties. Curr Pharm Biotechnol (2015) 0.75
[Recombinant adeno-associated virus vector related impurities]. Sheng Wu Gong Cheng Xue Bao (2011) 0.75
[Construction and activity of recombinant adeno-associated virus expressing vasostatin]. Sheng Wu Gong Cheng Xue Bao (2008) 0.75
An Insight into Glyco-microheterogeneity of Plasma von Willebrand Factor (vWF) by Mass Spectrometry. J Proteome Res (2017) 0.75
Classification in networked data with heterophily. ScientificWorldJournal (2013) 0.75
Observation Versus Resection for Small, Localized, and Nonfunctional Pancreatic Neuroendocrine Tumors: A Propensity Score Matching Study. Pancreas (2022) 0.75
[Innate immune mechanisms against recombinant adeno-associated virus vectors--a review]. Wei Sheng Wu Xue Bao (2012) 0.75
Protein submitochondrial localization from integrated sequence representation and SVM-based backward feature extraction. Mol Biosyst (2014) 0.75
Promising coagulation factor VIII bypassing strategies for patients with haemophilia A. Blood Coagul Fibrinolysis (2014) 0.75
[Large-scale production of recombinant adeno-associated virus (rAAV)]. Sheng Wu Gong Cheng Xue Bao (2009) 0.75
[Progress in application of targeting viral vector regulated by microRNA in gene therapy: a review]. Sheng Wu Gong Cheng Xue Bao (2010) 0.75
[Trends in development of self-complementary adeno-associated virus vector]. Sheng Wu Gong Cheng Xue Bao (2009) 0.75
The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.75
Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828). Expert Opin Ther Pat (2013) 0.75
[A new β-shaped intracorporeal Billroth II anastomosis technique after totally laparoscopic distal gastrectomy]. Zhonghua Wei Chang Wai Ke Za Zhi (2015) 0.75
Biochemical and enzymatic properties of a novel marine fibrinolytic enzyme from Urechis unicinctus. Appl Biochem Biotechnol (2007) 0.75
Community core evolution in mobile social networks. ScientificWorldJournal (2013) 0.75
Preparation and characterizations of polyclonal antibodies against STAR protein QKI7b. Appl Biochem Biotechnol (2013) 0.75
5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior. Bioorg Med Chem (2010) 0.75